PGEN FY2025 SEC EDGAR DEF 14A #97 of 168 in industry

Precigen, Inc. CEO pay ratio

The CEO earned $5.4M in FY2025 against median worker pay of $159,500 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
VA
Filing date
2026-04-30
Industry
Chemicals & Pharmaceuticals
Industry rank
#97/168

Data updated August 2026

Subscribe to Precigen, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
34:1
Below Average (Scale: 0–1000:1)
CEO pay
$5.4M
Median worker
$159,500

Answer first

Precigen, Inc.'s FY2025 CEO total of $5.4M ranks #904 of 1,423 complete filings; its 34:1 pay ratio ranks #1112. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $159,500. Industry placement uses the FY2025 SIC-28 peer cohort (# 97 of 168, 43rd percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#904
$5.4M of 1,423 FY2025
Ratio rank
#1112
34:1 of 1,423
Industry pct
43rd
below the industry median pay ratio

How Precigen, Inc. ranks nationally

Precigen, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$5,354,329 36th percentile higher than 36% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Precigen, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($5.4M) against pay ratio (34:1) for Precigen, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both04601554.09203107.913804661.918406215.932.5:135.0:137.5:140.0:142.5:1CEO total payPay ratio (CEO : median worker)Precigen, Inc., CEO total pay: 5354329 · Pay ratio (CEO : median worker): 34:1Precigen, Inc.Evolus, Inc., CEO total pay: 6412214 · Pay ratio (CEO : median worker): 35:1Evolus, Inc.Recursion Pharmaceuticals, Inc., CEO total pay: 9503538 · Pay ratio (CEO : median worker): 33:1Recursion Pharmaceuticals, Inc.Kiniksa Pharmaceuticals International, plc, CEO total pay: 310707 · Pay ratio (CEO : median worker): 35:1Kiniksa Pharmaceuticals International, plcGeron Corp, CEO total pay: 314826 · Pay ratio (CEO : median worker): 35:1Geron CorpRhythm Pharmaceuticals, Inc., CEO total pay: 17544525 · Pay ratio (CEO : median worker): 36:1Rhythm Pharmaceuticals, Inc.
Precigen, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Precigen, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Precigen, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
34:1
FY2025
vs prior FY
-1:1
from FY2024 35:1
CEO $ YoY
-1.4%
$5.4M latest
Filings shown
5
FY2021–2025
Precigen, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $2.5M - $80,070 31:1 -
2022 $3.5M +39% $115,000 30:1 -1:1
2023 $3.7M +6.3% $118,000 31:1 +1:1
2024 $5.4M +46% $155,000 35:1 +4:1
2025 $5.4M -1.4% $159,500 34:1 -1:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1356090, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
34:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$5.4M
Companies in Industry
168
vs. Industry Median
Below
#97 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Precigen, Inc.: MODEST · MID$ pay ratio

Precigen, Inc.'s 34:1 ratio ranks #1112 of 1,423 FY2025 complete filings (lower third by ratio). the CEO earned 34× the median employee ($159,500) in FY2025.

Median employee $159,500 (ELITE-MED); MODEST · MID$ stamps put about 34 median-wage years per CEO year.

CEO Total Pay

$5.4M

FY2025 Summary Compensation, below median

Pay Ratio

34:1

Below typical

Precigen, Inc. in the lower-ratio third

Precigen, Inc.'s 34:1 ratio ranks #1112 of 1,423 FY2025 complete filings (lower third by ratio). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Precigen, Inc.'s $5.4M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #904 and ratio rank #1112 split - treat 34:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$5.4M
Median Employee Pay
$159,500
Pay Ratio
34:1
Filing Date
2026-04-30

Company Info

Ticker
PGEN
CIK
1356090
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
VA
View SEC filings →
SEC EDGAR DEF 14A for CIK 1356090, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Precigen, Inc.'s 34:1 ratio ranks #1112 of 1,423 FY2025 complete filings (lower third by ratio).

Read with Precigen, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MID$ · ELITE-MED.

Zions Bancorporation, National Association /ut/ · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $6K heavier vs Precigen, Inc.); MODEST · HIGH-MED vs this page's MODEST · MID$ · ELITE-MED.
Lsb Industries, Inc. · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $10K heavier vs Precigen, Inc.); MODEST · HIGH-MED vs this page's MODEST · MID$ · ELITE-MED.
Peoples Bancorp Inc · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $10K heavier vs Precigen, Inc.); MID · PAR-MED vs this page's MODEST · MID$ · ELITE-MED.
Treace Medical Concepts, Inc. · MID$

ABS(ceo_total_comp) peer at $5.4M (Δ $16K heavier vs Precigen, Inc.); MODEST · ELITE-MED vs this page's MODEST · MID$ · ELITE-MED.
Evolus, Inc. (SIC 28 pole)

Evolus, Inc. stamps MODEST · HEAVY nearest in-SIC by ABS(pay_ratio) to Precigen, Inc.'s MODEST filing.
National dual ranks · #904/#1112

Precigen, Inc.'s FY2025 package sits #904 by CEO dollars and #1112 by ratio under MID$ · MODEST.
Ratio primer · MODEST

Precigen, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Precigen, Inc. (CIK 1356090), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.